SCHEMBL7456972

SCHEMBL7456972

CN(C)CCOP(N)(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.40
CHRM4 P08173 1/20 0.40
CHRM5 P08912 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRNB2 P17787 1/20 0.40
CHRM3 P20309 1/20 0.40
CHRNA4 P43681 1/20 0.40
MVD P53602 1/20 0.37
ANPEP P15144 1/20 0.36
CA12 O43570 2/20 0.34
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
CA9 Q16790 2/20 0.34
PHLPP2 Q6ZVD8 1/20 0.34
USP2 O75604 1/20 0.33
DNM1 Q05193 1/20 0.32
MAPT P10636 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
LPAR3 Q9UBY5 3/20 0.30
LPAR1 Q92633 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1642999 0.81 LPAR3 (0.46) CHRM2CHRM4CHRM5CHRM1CHRNB2
SCHEMBL7456978 0.81 CHRM2 (0.38) CHRM2CHRM4CHRM5CHRM1CHRNB2
SCHEMBL10937857 0.81 CHRM2 (0.38) CHRM2CHRM4CHRM5CHRM1CHRNB2
SCHEMBL7132612 0.79 CHRM2 (0.41) CHRM2CHRM4CHRM5CHRM1CHRNB2
SCHEMBL28992249 0.77 CHRM2 (0.34) CHRM2CHRM1CHRNB2CHRM3CHRNA4
SCHEMBL8232301 0.76 MVD (0.43) CHRM2CHRM4CHRM5CHRM1CHRNB2
SCHEMBL3029332 0.75 CYP3A4 (0.46) CHRM2CHRM4CHRM5CHRM1CHRNB2
SCHEMBL2471602 0.74 MVD (0.42) CHRM2CHRM4CHRM5CHRM1CHRNB2
SCHEMBL14750297 0.74 MVD (0.42) CHRM2CHRM4CHRM5CHRM1CHRNB2
SCHEMBL2628074 0.74 MVD (0.42) CHRM2CHRM4CHRM5CHRM1CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114249956-A Surface-modified metal oxide nanoparticle dispersion composition, method for producing same, film composition, and optical film 凯斯科技股份有限公司 2022-03-29 CN claimed
US-6462184-B2 PROVIDING A PURINE OR PYRIMIDINE BASE CONTAINING NUCLEOSIDE WITH ACID LABILE HYDROXYL PROTECTING GROUP AND A BASE LABILE HYDROXY PROTECTING GROUP SUBSTITUTIONS, DEBLOCKING HYDROXY GROUP, TREATING WITH PHOSPHONATE COMPOUND, CONDENSING AGENT ISIS PHARMACEUTICALS, INC. 2002-10-08 US disclosed
EP-1159282-A4 COMPOUNDS, PROCESSES AND INTERMEDIATES FOR SYNTHESIS OF MIXED BACKBONE OLIGOMERIC COMPOUNDS ISIS PHARMACEUTICALS INC (US) 2002-08-28 EP disclosed
EP-1159282-A1 COMPOUNDS, PROCESSES AND INTERMEDIATES FOR SYNTHESIS OF MIXED BACKBONE OLIGOMERIC COMPOUNDS ISIS PHARMACEUTICALS, INC. (US) 2001-12-05 EP disclosed
US-6207819-B1 SYNTHESIZING OLIGONUCLEOTIDE BY DEBLOCKING AND COUPLING NUCLEOTIDES TOGETHER, THEN TREATING WITH OXIDIZING SOLUTION TO CONVERT H-PHOSPHONATE LINKAGES TO PHOSPHODIESTER, PHOSPHOROTHIOATE, PHOSPHORAMIDATE OR BORANOPHOSPHATE ISIS PHARMACEUTICALS, INC. 2001-03-27 US disclosed
WO-2000047593-A1 COMPOUNDS, PROCESSES AND INTERMEDIATES FOR SYNTHESIS OF MIXED BACKBONE OLIGOMERIC COMPOUNDS ISIS PHARMACEUTICALS, INC. (US) 2000-08-17 WO disclosed